Power of Attorney for Kazia Therapeutics Ltd.

This filing is an Exhibit 24, a Limited Power of Attorney document for Kazia Therapeutics Ltd. The document designates John E. Friend II as the attorney-in-fact for James Levine, who is the Chief Financial Officer of the company. This power of attorney authorizes Friend to execute and file various U.S. Securities and Exchange Commission (SEC) forms on behalf of Levine, including Form ID, Form 3, Form 4, Form 5, and Schedules 13D and 13G, as well as any amendments. The attorney-in-fact is empowered to take any necessary actions to complete and file these forms with the SEC and other relevant authorities. The power of attorney remains in effect until Levine is no longer required to file such forms or until it is revoked. It also states that the attorney-in-fact is not assuming Levine’s responsibilities for compliance with Section 16 or Regulation 13D-G of the Securities Exchange Act of 1934, and Levine agrees to indemnify the attorney-in-fact and the Company against any claims arising from false information provided.